stockrow
Friday 6 November 2026
Export MDLN’s income statement to Excel — free account
Medline Inc.
MDLN Healthcare Medical Instruments & Supplies
Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.
- Revenue
- +14.1%
- Free cash flow
- +916.1%
- Total debt
- −23.7%
Quarter to September 2026, against a year earlier
39.96
0.39
−0.97%
Follow MDLN
Alert me
Medline Inc. (MDLN) Operating cash flow
Medline Inc.'s operating cash flow for fiscal 2025 was $1.7B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $3.9B. Medline Inc. ranks 3rd of 51 Medical Instruments & Supplies companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | $1.7B | (1.41%) |
| FY2024 | $1.8B | 4.99% |
| FY2023 | $1.7B | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $1.0B | 43.36% |
| Jun 2026 | $715.0M | 73.54% |
| Mar 2026 | $412.0M | (76.38%) |
| Dec 2025 | $1.7B | 785.28% |
| 4 more quarters | Free account |
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| ISRG Intuitive Surgical, Inc. compare | $4.1B |
| BDX Becton, Dickinson and Company compare | $4.0B |
| MDLN Medline Inc. | $3.9B |
| ALC Alcon compare | $2.3B |
| RMD ResMed Inc. compare | $1.8B |
| BAX Baxter International Inc. compare | $1.6B |
| COO The Cooper Companies, Inc. compare | $1.0B |
| WST West Pharmaceutical Services, Inc. compare | $654.5M |
| SOLV Solventum Corporation compare | $310.0M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item